Credence Genomics (Pte) Ltd
Credence Genomics is a diagnostics company specializing in next-generation sequencing (NGS) based infectious disease identification. Their proprietary platform offers rapid, cost-effective, and comprehensive pathogen detection and antibiotic resistance profiling, primarily targeting sepsis and antimicrobial resistance (AMR). Key products include Bactfast® for bacterial identification, Fungifast® for fungal detection, Virfast® for viral screening, and digitalABST® for antibiotic resistance analysis using machine learning. Their solutions are CE-IVD certified and used in clinical settings such as ICUs, providing results within 36 hours with high accuracy. The company operates in multiple countries including Singapore, India, and Sri Lanka, serving healthcare providers and hospitals to improve infectious disease diagnostics and treatment precision.
Credence Genomics (Pte) Ltd
Credence Genomics is a diagnostics company specializing in next-generation sequencing (NGS) based infectious disease identification. Their proprietary platform offers rapid, cost-effective, and comprehensive pathogen detection and antibiotic resistance profiling, primarily targeting sepsis and antimicrobial resistance (AMR). Key products include Bactfast® for bacterial identification, Fungifast® for fungal detection, Virfast® for viral screening, and digitalABST® for antibiotic resistance analysis using machine learning. Their solutions are CE-IVD certified and used in clinical settings such as ICUs, providing results within 36 hours with high accuracy. The company operates in multiple countries including Singapore, India, and Sri Lanka, serving healthcare providers and hospitals to improve infectious disease diagnostics and treatment precision.